Now showing items 1-4 of 4

    • Beta-blocker exposure and survival in patients with transthyretin amyloid cardiomyopathy 

      Barge-Caballero, Gonzalo; Barge-Caballero, Eduardo; López-Pérez, Manuel; Bilbao-Quesada, Raquel; González-Babarro, Eva; Gómez-Otero, Inés; López-López, Andrea; Gutiérrez-Feijoo, Mario; Varela-Román, Alfonso; González-Juanatey, Carlos; Díaz-Castro, Óscar; Crespo-Leiro, María Generosa (Elsevier, 2022-02)
      [Abstract] Objective: To investigate a potential association between beta-blocker exposure and survival in patients with transthyretin amyloid cardiomyopathy (ATTR-CM). Methods: In this real-world prospective registry ...
    • Cardiac amyloidosis: description of a series of 143 cases 

      Barge-Caballero, Gonzalo; Barge-Caballero, Eduardo; López-Pérez, Manuel; Bilbao-Quesada, Raquel; González-Babarro, Eva; Gómez-Otero, Inés; López-López, Andrea; Gutiérrez-Feijoo, Mario; Varela-Román, Alfonso; González-Juanatey, Carlos; Díaz-Castro, Óscar; Crespo-Leiro, María Generosa (Elsevier, 2022-09-09)
      [Abstract] Introduction and objectives: Recently, there have been important advances in the diagnosis and treatment of cardiac amyloidosis (CA). Our aim was to provide an updated description of its 2 most frequent types: ...
    • Prevalence, Incidence, and Outcomes of Hyperkalaemia in Patients with Chronic Heart Failure and Reduced Ejection Fraction from a Spanish Multicentre Study: SPANIK-HF Design and Baseline Characteristics 

      Delgado-Jiménez, Juan F.; Segovia-Cubero, Javier; Almenar-Bonet, Luis; Juan-Bagudá, Javier de; Lara-Padrón, Antonio; García-Pinilla, José Manuel; Bonilla-Palomas, Juan Luis; López-Fernández, Silvia; Mirabet-Pérez, Sonia; Gómez-Otero, Inés; Castro-Fernández, Antonio; Díaz-Molina, Beatriz; Goirigolzarri-Artaza, Josebe; Rincón-Pérez, Luis Miguel; Pascual-Figal, Domigo A.; Anguita-Sánchez, Manuel; Muñiz, Javier; Crespo-Leiro, María Generosa (MDPI, 2022-02-22)
      [Abstract] Hyperkalaemia is a growing concern in the treatment of patients with heart failure and reduced ejection fraction (HFrEF) as it limits the use of some prognostic-modifying drugs and has a negative impact on ...
    • Syncope in patients with transthyretin amyloid cardiomyopathy: clinical features and outcomes 

      Barge-Caballero, Gonzalo; Barge-Caballero, Eduardo; López-Pérez, Manuel; Bilbao-Quesada, Raquel; González-Babarro, Eva; Gómez-Otero, Inés; López-López, Andrea; Gutiérrez-Feijoo, Mario; Varela-Román, Alfonso; González-Juataney, Carlos; Díaz-Castro, Óscar; Crespo-Leiro, María Generosa (Taylor & Francis, 2022-03-23)
      [Abstract] Background: We aimed to describe the clinical characteristics, underlying causes and outcomes of syncope in patients with transthyretin amyloid cardiomyopathy (ATTR-CM). Methods: The clinical profile and ...